Rare and Orphan Diseases

Episodes 1-16 of 26

Exploring Patient Perspectives on Genetic Testing for ATTR-CM
Exploring Patient Perspectives on Genetic Testing for ATTR-CM
On the Frontlines of ATTR-CM
Exploring Patient Perspectives on Genetic Testing for ATTR-CM
- Shelina Ramnarine, PhD
- Quan Bui, MD
Managing Genotype-Positive Patients in Hereditary ATTR-CM
Managing Genotype-Positive Patients in Hereditary ATTR-CM
On the Frontlines of ATTR-CM
Managing Genotype-Positive Patients in Hereditary ATTR-CM
- Shelina Ramnarine, PhD
- Naveen L. Pereira, MD
The Cost of Progress: Examining Barriers to ATTR-CM Care
The Cost of Progress: Examining Barriers to ATTR-CM Care
On the Frontlines of ATTR-CM
The Cost of Progress: Examining Barriers to ATTR-CM Care
- Charles Turck, PharmD, BCPS, BCCCP
- Michelle Kittleson, MD, PhD
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Heart Matters
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Heart Matters
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
- Ryan Quigley
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
On the Frontlines of ATTR-CM
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
- Ryan Quigley
- Farooq Hameed Sheikh, MD
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Heart Matters
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
- Kevin Alexander, MD
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Heart Matters
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
- Kevin Alexander, MD
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Heart Matters
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Heart Matters
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Heart Matters
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Heart Matters
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
- Ahmad Masri, MD, MS
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Heart Matters
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
- Ahmad Masri, MD, MS
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Heart Matters
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Heart Matters
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD

1/2

Episodes 1-16 of 26

Title

Share on ReachMD

Welcome to Global Cardiology Academy

Welcome to Global
Cardiology Academy